Clinical

Articles

These research and technology breakthroughs are designed to improve outcomes and the patient experience.

Cleveland Clinic highlights 5 innovations that are changing the delivery of prostate cancer care

This real-world cohort study corroborates prior research showing a greater clinical benefit for abiraterone acetate in African American versus White patients with metastatic castration-resistant prostate cancer. 

Survival with frontline abiraterone higher for African American vs White men with mCRPC

Researchers uncover how diet, lifestyle modifications may lower risk of lethal disease.

Cleveland Clinic Study Links Gut Microbiome and Aggressive Prostate Cancer

Podcasts

“It doesn't need to be surgery or radiation. Setting that stage, really focusing on those conversations, using the appropriate tools that we've grasped from behavioral psychologists that are being used by negotiation specialists, are critical in medicine,” says Behfar Ehdaie, MD, MPH.

Destigmatizing Urology: Dr. Ehdaie discusses active surveillance

The improved response to radiotherapy was observed despite Black men having more aggressive disease at enrollment. 

Study suggests radiotherapy response is better among Black men versus White men with prostate cancer

Benjamin P. Saylor is associate editor of Urology Times, an Advanstar Communications publication.

“We’ll be able to take a drop of blood in a community setting such as a barbershop and be able to deliver results in 10 to 15 minutes right there,” says investigator Saurabh Mehta, ScD.

Kit may offer fast and portable method for PSA screening

Videos

“I think in specialized cases, especially for patients [who] need focal therapy or want focal therapy, or [for whom] you're really trying to minimize any nerve damage or urethral damage…these are excellent therapies,” says Jennifer Linehan, MD.

Dr. Linehan on advancements in minimally invasive and robotic technologies

Karen Nash is a medical reporter and media consultant based in Monroeville, PA.

"There are many aspects of urology that get equal attention. Cancer will always attract attention and dollars, but it’s trickier to solve," says 1 urologist.

With all the attention paid to prostate cancer research and treatment, do other aspects of urology get the research they need?

William J. Catalona, MD, explains how prostate-specific antigen (PSA) testing revolutionized screening and treatment of prostate cancer. 

Prostate-specific antigen–based screening ushers in an era of change

"The fact that it was a simple blood test, it was absolutely objective, and it was…non-invasive…made it very attractive," says William J. Catalona, MD.